The answer is "cost, accessibility, training, and professional ethics".
These dramatic advances, however, will be joined by new and vexing issues of cost, accessibility, training, and professional ethics. The accessibility of new learning additionally unfathomably surpasses the limit of the organizations that convey and fund medicinal services to access and use it. The huge potential for good that the U.S. medicinal services framework appreciates accompanies profound concerns.